Document is current
Any future updates will be listed below
-
Authors
Dubrovin Leão, Douglas
Khorikian-Ghazari, Naiiri
Halms, Theresa
Strasser, Anna Martina
Ianovska, Iana
Karcher, Sinan
Rabenstein, Andrea
Rüther, Tobias
Hasan, Alkomiet
Gertzen, Marcus
-
Funding
Funding for this research was provided by:
Universität Augsburg medizinische Fakultät
Universität Augsburg
- License Information
-
More Information
Article History
Accepted: 25 February 2025
First Online: 18 March 2025
Declarations
:
: This study is part of the doctoral thesis of Douglas Dubrovin Leão at the Faculty of Medicine, Augsburg University, Augsburg. Mr. Dr. med. Marcus Gertzen. Co-Founder of the “Junge Suchtmedizin”-Initiative, Chairman of the Board of the Federal Initiative on Sexualized Substance Use (BISS e.V.), Research funding by the Medical Faculty of the University of Augsburg, Lectures for the company Gilead, Hexal, as well as various drug aid and AIDS aid organizations in the German and Austrian area. Mr. Univ-Prof Dr. med. Alkomiet Hasan. Publisher of the WFSBP and DGPPN guidelines for schizophrenia and member or the IFCN-guideline group for rTMS treatment. AH received paid speakerships from Desitin, Janssen, Otsuka, and Lundbeck and was member of the Roche, Otsuka, Lundbeck, and Janssen Cilag advisory boards. The other authors declare that they have no conflict of interest.
